Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Gastroenterology
Published in: Current Treatment Options in Gastroenterology 3/2017

01-09-2017 | Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Intractable Constipation in the Elderly

Authors: Noemi Baffy, MD, MPH, Amy E. Foxx-Orenstein, DO, Lucinda A. Harris, MD, Susan Sterler, RN

Published in: Current Treatment Options in Gastroenterology | Issue 3/2017

Login to get access

Opinion statement

Chronic constipation is a common gastrointestinal disorder disproportionately affecting the elderly. Immobility, polypharmacy, and physiologic changes contribute to its increased prevalence in this population. Unidentified and undertreated constipation leads to a significant negative impact on quality of life and an increase in healthcare spending. Careful physical examination and exploration of the clinical history can unmask primary and secondary forms of constipation, guiding diagnostic and therapeutic considerations. Non-pharmacologic treatment options include bowel training and biofeedback as well as the addition of fiber. Laxatives are safe and can be used long term; thus, they remain the mainstay of therapy. Newer agents with specific physiologic targets have proven to be effective in adults with chronic constipation, but data is lacking for safety profile in the elderly. Consideration for surgery in medically refractory cases should be entertained, while use of neuromodulation is not ready for prime time. This is a review of the currently available treatment options for chronic constipation in adults and specifically tailored towards the elderly.
Literature
1.
Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750–9.PubMedCrossRef
2.
• Bharucha AE, Pemberton JH, Locke GR III. American Gastroenterological Association technical review on constipation. Am Gastroenterol Assoc Gastroenterol. 2013;144:218–38. This is a general overview of the recent diagnostic and therapeutic advances in constipation, with a focus directed at gastroenterologists
3.
Locke GR III, Pemberton JH, Phillips SF. AGA technical review on constipation. Am Gastroenterol Assoc Gastroenterol. 2000;119:1766–78.
4.
Choung RS, Locke GR, Schleck CD, et al. Cumulative incidence of chronic constipation: a population-based study 1988–2003. Aliment Pharmacol Ther. 2007;26(11–12):1521–8.PubMedCrossRef
5.
Hsieh C. Treatment of constipation in older adults. Am Fam Physician. 2005;72(11):2277–84.PubMed
6.
Gallogos-Orozco JF, Foxx-Orenstein AE, Sterler SM, et al. Chronic constipation in the elderly. Am J Gastroenterol. 2012;107(1):18–25.CrossRef
7.
Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–4.PubMedCrossRef
8.
Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91(1):19–25.PubMed
9.
Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with severe idiopathic constipation. Gastroenterology. 1989;97(4):932–7.PubMedCrossRef
10.
Merkel IS, Locher J, Burgio K, et al. Physiologic and psychologic characteristics of an elderly population with chronic constipation. Am J Gastroenterol. 1993;88(11):1854–9.PubMed
11.
Rao SS, Seaton K, Miller MJ, et al. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res. 2007;63:441–9.PubMedCrossRef
12.
O’Keefe EA, Talley NJ, Tangalos EG, et al. A bowel symptom questionnaire for the elderly. J Gerontol. 1992;47:M116–21.PubMedCrossRef
13.
Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord. 2004;4(Suppl 2):S3–10.PubMed
14.
Drossman D, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 150(6):1257–61.
15.
Lovell R, Ford A. Global prevalence of, and risk factors for, irritable bowel syndrome: a meta- analysis. Clin Gastroenterol Hepatol. 2012;10:712–21.PubMedCrossRef
16.
Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am. 2007;36:687–711.PubMedCrossRef
17.
18.
Vazquez Roque M, Bouras EP. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging. 2015;10:919–30.PubMedPubMedCentral
19.
Koch TR, Carney JA, Go VL, et al. Inhibitory neuropeptides and intrinsic inhibitory innervation of descending human colon. Dig Dis Sci. 1991;36:712–8.PubMedCrossRef
20.
21.
Bassotti G, Villanacci V. Can “functional” constipation be considered as a form of enteric neuro-gliopathy? Glia. 2011;59:345–50.PubMedCrossRef
22.
Camilleri M, Lee JS, Viramontes B, et al. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000;48:1142–50.PubMedCrossRef
23.
•• Rao SSC, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430–1442.e4. This is a comprehensive review of the most recent advances in diagnosis and management of anorectal disorders which is a subset of patients with chronic constipationCrossRef
24.
Fox JC, Fletcher JG, Zinsmeister AR, et al. Effect of aging on anorectal and pelvic floor functions in females. Dis Colon Rectum. 2006;49:1726–35.PubMedCrossRef
25.
Roach M, Christie JA. Fecal incontinence in the elderly. Geriatrics. 2008;63:13–22.PubMed
26.
Bassotti G, Chiarioni G, Vantini I, et al. Anorectal manometric abnormalities and colonic propulsive impairment in patients with severe chronic idiopathic constipation. Dig Dis Sci. 1994;39:1558–64.PubMedCrossRef
27.
•• Yu SW, Rao SS. Anorectal physiology and pathophysiology in the elderly. Clin Geriatr Med. 2014;30(1):95–106. This is an excellent review of the physiologic changes the body undergoes as it ages with a particular focus on alterations to the mechanics of defecationPubMedPubMedCentralCrossRef
28.
Papachrysostomou M, Pye SD, Wild SR, et al. Significance of the thickness of the anal sphincters with age and its relevance in faecal incontinence. Scand J Gastroenterol. 1994;29:710–4.PubMedCrossRef
29.
Klosterhalfen B, Offner F, Topf N et al. Sclerosis of the internal anal sphincter, a process of aging. Dis Colon Rectum. 1990;33:606–609.
30.
Harari D. Constipation. In: Halter JB, Ouslander JG, Tinetti ME, editors. Hazzard’s geriatric medicine and gerontology. 6th ed. New York, USA: McGraw-Hill Companies; 2009. p.1103–1122.
31.
Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am. 2009;38:463–80.PubMedCrossRef
32.
Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. Am Geriatr Soc. 1989;37:423–9.CrossRef
33.
Iovino P, Chiarioni G, Bilancio G, et al. New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility induced bowel changes. PLoS One. 2013;20:e72608.CrossRef
34.
Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008;103(4):820–2.PubMedCrossRef
35.
Tantiphlachiva K, Rao P, Attaluri A, et al. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol. 2010;8(11):955–60.PubMedCrossRef
36.
37.
38.
Fletcher JG, Busse RF, Riederer SJ, et al. Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol. 2003;98(2):399–411.PubMedCrossRef
39.
40.
Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology. 1987;92(1):40–7.PubMedCrossRef
41.
Rao SS, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–44.PubMedCrossRef
42.
Irvine EJ, Ferrazzi S, Pare P, et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986–93.PubMedCrossRef
43.
Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther. 2007;26:237–48.PubMedCrossRef
44.
Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33:818–24.PubMedPubMedCentralCrossRef
45.
Bharucha AE, Rao SS. An update on anorectal disorders for gastroenterologists. Gastroenterology. 2014;146(1):37–45.e2.PubMedCrossRef
46.
Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657–64.PubMedCrossRef
47.
Ba-Bai-Ke-Re MM, Wen NR, Hu YL, et al. Biofeedback-guided pelvic floor exercise therapy for obstructive defecation: an effective alternative. World J Gastroenterology. 2014;20:9162–9.
48.
Simón MA, Bueno AM. Behavioural treatment of the dyssynergic defecation in chronically constipated elderly patients: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2009;34(4):273–7.PubMedCrossRef
49.
Wang X, Yin J. Complementary and alternative therapies for chronic constipation. Evidence-Based Complementary and Alternative Medicine. 2015, Article ID 396396.
50.
Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011;33(8):895–901.PubMedCrossRef
51.
Ford AC, Moayyedi P, Lacy BE, et al.; 2014 Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol.;109(Suppl 1):S2–S26.
52.
Lawton CL, Walton J, Hoyland A, et al. Short term (14 days) consumption of insoluble wheat bran fibre-containing breakfast cereals improves subjective digestive feelings, general wellbeing and bowel function in a dose dependent manner. Nutrients. 2013;5(4):1436–55.PubMedPubMedCentralCrossRef
53.
Andersson H, Bosaeus I, Falkheden T, et al. Transit time in constipated geriatric patients during treatment with a bulk laxative and bran: a comparison. Scand J Gastroenterol. 1979;14(7):821–6.PubMedCrossRef
54.
Nour-Eldein H, Salama HM, Abdulmajeed AA, et al. The effect of lifestyle modification on severity of constipation and quality of life of elders in nursing homes at Ismailia city. Egypt. J Family Community Med. 2014 May;21(2):100–6.PubMedCrossRef
55.
• Markland AD, Palsson O, et al. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol. 2013;108(5):796–803. This article investigated the association between dietary fiber and fluid intake and constipation using the NHANES patient information. Their findings indicate that lower fluid intake but not low fiber intake was associated with a higher prevalence of constipationPubMedPubMedCentralCrossRef
56.
Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.PubMedPubMedCentralCrossRef
57.
Bartosch S, Fite A, Macfarlane GT, et al. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004;70:3575–81.PubMedPubMedCentralCrossRef
58.
Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48:198–205.PubMedPubMedCentralCrossRef
59.
60.
Food and Agriculture Organization of the United Nations and WHO Working Group. Guidelines for the evaluation of probiotics in food. Geneva, Switzerland: FAO/WHO, 2002.
61.
Dimidi E, Christodoulides S, et al. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(4):1075–84.PubMedCrossRef
62.
Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100(4):936–71.PubMedCrossRef
63.
Castle SC, Cantrell M, Israel DS, et al. Constipation prevention: empiric use of stool softeners questioned. Geriatrics. 1991;46(11):84–6.PubMed
64.
65.
Chassagne P, Jego A, Gloc P, et al. Does treatment of constipation improve faecal incontinence in institutionalized elderly patients? Age Ageing. 2000;29:159–64.PubMedCrossRef
66.
Leung FW, Rao SS. Approach to fecal incontinence and constipation in older hospitalized patients. Hosp Pract. 2011;39(1):97–104.CrossRef
67.
Mendoza J, Legido J, Rubio S, et al. Systematic review: the adverse effects of sodium phosphate enema. Aliment Pharmacol Ther. 2007;26:9–20.PubMedCrossRef
68.
Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461–76.PubMedCrossRef
69.
Menees SB, Guentner A, Chey SW, et al. How do US gastroenterologists use over-the-counter and prescription medications in patients with gastroesophageal reflux and chronic constipation? Am J Gastroenterol. 2015;110(11):1516–25.PubMedCrossRef
70.
71.
Cirillo C, Capasso R. Constipation and botanical medicines: an overview. Phytother Res. 2015;10:1488–93.CrossRef
72.
Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol. 2003;36(5):386–9.PubMedCrossRef
73.
Müller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100(1):232–42.PubMedCrossRef
74.
Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–18.PubMedCrossRef
75.
Jones MP, Talley NJ, Nuyts G, et al. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002;47(10):2222–30.PubMedCrossRef
76.
Nyberg C, Hendel J, Nielsen OH. The safety of osmotically acting cathartics in colonic cleansing. Nat Rev Gastroenterol Hepatol. 2010;7(10):557–64.PubMedCrossRef
77.
Crowell MD, Harris LA, Lunsford TN, et al. Emerging drugs for chronic constipation. Expert Opin Emerg Drugs. 2009;14:493–504.PubMedCrossRef
78.
Ueno R, Joswick TR, Wahle A et al. Efficacy and safety of lubiprostone for the treatment of chronic constipation in elderly vs non-elderly subjects. Gastroenterology. 2006;130(Suppl 2):A189. Abstract S1262.
79.
Ueno R, Panas R, Wahle A, Zhu Y, Holland PC. Long-term safety and efficacy of lubiprostone for the treatment of chronic constipation in elderly subjects. Gastroenterology. 2006;130 (Suppl 2):A-188. Abstract S1260.
80.
Ueno R, Wahle A, Rivera E. Pooled analysis of the most frequent adverse events associated with the use of lubiprostone. Am J Gastroenterol. 2006;101(Suppl 2):S489. Abstract 1264.
81.
Lembo AJ, Kurtz CB, Macdougall JE, et al. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010;138:886–95.PubMedCrossRef
82.
83.
De Giorgio R, Barbara G, Furness JB, et al. Novel therapeutic targets for myenteric nervous system disorders. Trends Pharmacol Sci. 2007;28:473–81.PubMedCrossRef
84.
Ke M, Zou D, Yuan Y, et al. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterology and Motility. 2012;24(11):999–e541.PubMedPubMedCentralCrossRef
85.
Shin A, Camilleri M, Kolar G, et al. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther. 2013;39:239–53.PubMedCrossRef
86.
87.
Müller-Lissner S, Rykx A, Kerstens R, et al. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil. 2010 Sep;22(9):991–8. e255
88.
Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci. 1980;25(6):433–8.PubMedCrossRef
89.
Chey WD, Camilleri M, Chang L, et al. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011 Oct;106(10):1803–12.PubMedPubMedCentralCrossRef
90.
Camilleri M, Acosta A. Relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015;27:324–32.PubMedCrossRef
91.
Acosta A, Camilleri M, Kolar G, et al. Relamorelin relieves constipation and accelerates colonic transit in a phase 2, placebo-controlled, randomized trial. Clin Gastroenterol Hepatol. 2015;13(13):2312–9.PubMedCrossRef
92.
Acosta A, Camilleri M, et al. Short-term effects of relamorelin on descending colon motility in chronic constipation: a randomized, controlled trial. Dig Dis Sci. 2016;61(3):852–60.PubMedCrossRef
93.
Leppert W. Emerging therapies for patients with symptoms of opioid-induced bowel function. Drug Design, Dev Ther. 2015;9:2215–31.CrossRef
94.
Hughes SF, Scott SM, Pilot MA, et al. Electrically stimulated colonic reservoir for total anorectal reconstruction. Br J Surg. 1995;82(10):1321–6.PubMedCrossRef
95.
Thaha MA, Abukar AA, Thin NN, et al. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev. 2015;24(8):CD004464.
96.
Ron Y, Halpern Z, Safari R, Dickman R, Dekel R, Sperber AD. Safety and efficacy of the vibrating capsule, an innovative non-pharmacological treatment modality for chronic constipation. Neurogastroenterol Motil. 2015;27(1):99–104.
97.
• Arebi N, Kalli T, Howson W, et al. Systematic review of abdominal surgery for chronic idiopathic constipation. Colorectal Dis. 2011:1335–43. This is a systematic review of the common surgical options available for treatment of chronic constipation with a critical appraisal of their outcome. Surgical measures seem to improve stool frequency and lead to patient satisfaction.
98.
99.
Van Laarhoven C, Kamm M, Bartram C et al. Relationship between anatomic and symptomatic long-term results after rectocele repair for impaired defecation. Dis Colon Rectum 1999;42:204–210.
100.
Albanese A, Maria G, Bentivoglio AR, et al. Severe constipation in Parkinson’s disease relieved by botulinum toxin. Mov Disord. 1997 Sep;12(5):764–6.PubMedCrossRef
Metadata
Title
Intractable Constipation in the Elderly
Authors
Noemi Baffy, MD, MPH
Amy E. Foxx-Orenstein, DO
Lucinda A. Harris, MD
Susan Sterler, RN
Publication date
01-09-2017
Publisher
Springer US
Published in
Current Treatment Options in Gastroenterology / Issue 3/2017
Print ISSN: 1092-8472
Electronic ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-017-0142-2

Other articles of this Issue 3/2017

Current Treatment Options in Gastroenterology 3/2017 Go to the issue

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

Dysphagia in the Elderly

Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)

The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly

Endoscopy (P Siersema, Section Editor)

Endoscopic Surveillance in Long-standing Colitis

Endoscopy (P Siersema, Section Editor)

Quality Indicators in Colonoscopy

Endoscopy (P Siersema, Section Editor)

Endoscopic Stents for the Biliary Tree and Pancreas

Pancreas (V Chandrasekhara, Section Editor)

Endoscopic Palliation of Pancreatic Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits